Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, 1688 Meiling Avenue, Nanchang 330004, China.
Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, 1688 Meiling Avenue, Nanchang 330004, China.
J Pharm Sci. 2024 Mar;113(3):699-710. doi: 10.1016/j.xphs.2023.08.024. Epub 2023 Sep 1.
The oral bioavailability of poorly soluble drugs has always been the focus of pharmaceutical researchers. We innovatively combined nanocrystal technology and solid dispersion technology to prepare novel nanocrystalline solid dispersions (NCSDs), which enable both the solidification and redispersion of nanocrystals, offering a promising new pathway for oral delivery of insoluble Chinese medicine ingredients. The rubusoside (Rub) was first used as the multifunctional stabilizer of novel apigenin nanocrystal-based solid dispersions (AP-NSD), improving the in vitro solubilization rate of the insoluble drug apigenin(AP). AP-NSD has been produced using a combination of homogenisation and spray-drying technology. The effects of stabilizer type and concentration on AP nanosuspensions (AP-NS) particles, span, and zeta potential were studied. And the effects of different types of protective agents on the yield and redispersibility of AP-NSD were also studied. Furthermore, AP-NSD was characterized by infrared spectroscopy (IR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD). Solubility was used to assess the in vitro dissolution of AP-NSD relative to APIs and amorphous solid dispersions (AP-ASD), and AP-ASD was prepared by the solvent method. The results showed that 20% Rub stabilized AP-NSD exhibited high drug-loading and good redispersibility and stability, and higher in vitro dissolution rate, which may be related to the presence of Rub on surface of drug. Therefore provides a natural and safe option for the development of formulations for insoluble drugs.
难溶性药物的口服生物利用度一直是药物研究人员关注的焦点。我们创新性地将纳米晶体技术和固体分散体技术相结合,制备了新型纳米晶固体分散体(NCSD),使纳米晶体既可以固化又可以重新分散,为难溶性中药成分的口服给药提供了有前途的新途径。毛蕊花糖苷(Rub)首次被用作新型芹菜素基于纳米晶体的固体分散体(AP-NSD)的多功能稳定剂,提高了难溶性药物芹菜素(AP)的体外溶解度。AP-NSD 是通过匀化和喷雾干燥技术结合生产的。研究了稳定剂类型和浓度对 AP 纳米悬浮液(AP-NS)颗粒、跨度和zeta 电位的影响。还研究了不同类型的保护剂对 AP-NSD 的产率和再分散性的影响。此外,通过红外光谱(IR)、扫描电子显微镜(SEM)、透射电子显微镜(TEM)、差示扫描量热法(DSC)和粉末 X 射线衍射(PXRD)对 AP-NSD 进行了表征。采用溶解度评估 AP-NSD 相对于 API 和无定形固体分散体(AP-ASD)的体外溶出度,AP-ASD 是通过溶剂法制备的。结果表明,20% Rub 稳定的 AP-NSD 表现出较高的载药量、良好的再分散性和稳定性,以及较高的体外溶出度,这可能与 Rub 存在于药物表面有关。因此,为开发难溶性药物制剂提供了一种天然、安全的选择。